Jane Street
KURA icon

Jane Street’s Kura Oncology KURA Stock Holding History

Jane Street’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$816K Sell
74,383
-588,967
-89% -$5.56M ﹤0.01% 6962
2026
Q1 		$5.39M Buy
663,350
+186,205
+39% +$1.6M ﹤0.01% 3397
2025
Q4 		$4.96M Buy
477,145
+231,323
+94% +$2.43M ﹤0.01% 3239
2025
Q3 		$2.18M Buy
245,822
+75,198
+44% +$536K ﹤0.01% 4782
2025
Q2 		$985K Buy
170,624
+70,934
+71% +$435K ﹤0.01% 5651
2025
Q1 		$658K Sell
99,690
-526
-0.5% -$4.1K ﹤0.01% 6359
2024
Q4 		$873K Sell
100,216
-25,869
-21% -$372K ﹤0.01% 5639
2024
Q3 		$2.46M Buy
126,085
+33,848
+37% +$686K ﹤0.01% 4053
2024
Q2 		$1.9M Sell
92,237
-69,836
-43% -$1.44M ﹤0.01% 4573
2024
Q1 		$3.46M Buy
162,073
+63,758
+65% +$1.24M ﹤0.01% 3186
2023
Q4 		$1.41M Buy
+98,315
New +$967K ﹤0.01% 4926
2023
Q3 		– Sell
-93,053
Closed -$985K – 9042
2023
Q2 		$985K Buy
93,053
+23,062
+33% +$273K ﹤0.01% 5207
2023
Q1 		$856K Buy
69,991
+58,702
+520% +$733K ﹤0.01% 5311
2022
Q4 		$140K Sell
11,289
-14,230
-56% -$207K ﹤0.01% 7907
2022
Q3 		$349K Buy
25,519
+7,186
+39% +$111K ﹤0.01% 7336
2022
Q2 		$336K Buy
18,333
+8,057
+78% +$116K ﹤0.01% 7421
2022
Q1 		$165K Sell
10,276
-3,167
-24% -$45.7K ﹤0.01% 9165
2021
Q4 		$188K Buy
+13,443
New +$218K ﹤0.01% 8860
2021
Q3 		– Sell
-20,045
Closed -$378K – 10357
2021
Q2 		$418K Sell
20,045
-2,136
-10% -$53K ﹤0.01% 7573
2021
Q1 		$627K Sell
22,181
-31,940
-59% -$1.01M ﹤0.01% 6386
2020
Q4 		$1.77M Buy
54,121
+37,586
+227% +$1.32M ﹤0.01% 3718
2020
Q3 		$507K Buy
+16,535
New +$365K ﹤0.01% 5130
2020
Q1 		– Sell
-31,996
Closed -$440K – 5684
2019
Q4 		$440K Buy
+31,996
New +$474K ﹤0.01% 3836
2019
Q3 		– Sell
-13,628
Closed -$268K – 5457
2019
Q2 		$268K Buy
+13,628
New +$226K ﹤0.01% 4349

Other funds holding KURA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $241M AUM 112.74% 1-Year Est. Return

Jane Street's KURA Position: Q2 2026 in Review

Jane Street reduced its Kura Oncology (KURA) stake by 89% in Q2 2026, selling an estimated $5.56M and leaving 74,383 shares worth $816K. The position accounts for ﹤0.01% of the portfolio, ranked #6962.

Jane Street first reported a position in KURA in Q2 2019 and has held it in 24 quarters since. The position peaked at $5.39M in Q1 2026. 220 funds tracked by Wall St. Rank hold KURA as of Q2 2026.

  • Jane Street held 74,383 shares of Kura Oncology worth $816K as of Q2 2026.
  • Jane Street sold 588,967 Kura Oncology shares in Q2 2026, an estimated $5.56M.
  • Kura Oncology made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #6962 holding.
  • Jane Street first reported a position in Kura Oncology in Q2 2019 and has held it in 24 quarters since.
  • Jane Street's Kura Oncology position peaked at $5.39M in Q1 2026.
  • 220 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.